GlassScriptPhysician profile
Jose M Wiley
NPI 1366542284
$33,590.91
in general payments reported to CMS, 2019-2025
35 companies · $3,005 in 2025
The $3,005 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $3,499 · 2020: $4,750 · 2021: $14K · 2022: $3,145 · 2023: $2,751 · 2024: $2,202 · 2025: $3,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,303 · Travel and Lodging: $1,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,302.56 |
| Travel and Lodging | $1,654.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $10,787.71 | 2021-2025 | Orsiro Mission |
| Abbott Laboratories | $4,226.46 | 2019-2025 | Perclose Proglide, Esprit, Cardiomems |
| Medtronic Vascular, INC. | $2,481.27 | 2019-2020 | |
| Edwards Lifesciences Corporation | $2,174.57 | 2020-2025 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $2,092.40 | 2021-2025 | Symplicity G3, Resolute Onyx, In.Pact Admiral |
| Abiomed | $1,923.41 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,501.59 | 2020-2025 | Avvigo Guidance System, Rotapro |
| Cardiovascular Systems INC. | $1,190.02 | 2019-2022 | |
| Philips North America LLC | $1,055.81 | 2019-2023 | |
| Omega Medical Imaging, LLC | $723.60 | 2025 | |
| Avinger INC. | $703.71 | 2019-2020 | |
| Angiodynamics, INC. | $629.95 | 2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Cook Medical LLC | $588.29 | 2019-2023 | Zilver Ptx |
| Amgen INC. | $481.67 | 2020-2024 | Repatha |
| Scpharmaceuticals INC. | $431.94 | 2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $308.96 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Esperion Therapeutics, INC. | $272.53 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $246.39 | 2019 | |
| Spectrawave, INC | $236.55 | 2023 | Hypervue Imaging System |
| Biosense Webster, INC. | $198.43 | 2021-2022 | |
| Venturemed Group, INC. | $164.33 | 2020 | |
| Livanova USA, INC. | $136.31 | 2023-2024 | Lifesparc |
| Astrazeneca Pharmaceuticals LP | $121.81 | 2020 | |
| Bard Peripheral Vascular, INC. | $120.39 | 2019 | |
| W. L. Gore & Associates, INC. | $115.13 | 2021-2023 | Gore Cardioform Septal Occluder |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.55 | 2020-2025 | Lifevest |
| Stryker Corporation | $102.11 | 2025 | Limflow System |
| Siemens Medical Solutions USA, INC. | $96.49 | 2025 | Artis Icono Biplane |
| Saranas, INC. | $81.27 | 2022 | |
| Cardiva Medical, INC. | $71.72 | 2025 | Savvywire |
| Terumo Medical Corporation | $66.18 | 2022 | |
| Acist Medical Systems, INC. | $48.83 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $39.02 | 2022 | |
| Cardinal Health 200 LLC | $35.96 | 2019 | |
| Penumbra, INC. | $22.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$21,779.60 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Wiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.